证券代码：603113 证券简称：金能科技 债券代码：113545 债券简称：金能转债 金能科技股份有限公司 公开发行 A 股可转换公司债券 受托管理事务报告 （2024 年度） 债券受托管理人 二〇二五年六月 重要声明 本报告依据《公司债券发行与交易管理办法》（以下简称"《管理办法》"）《金 能科技股份有限公司 2019 年度公开发行 A 股可转换公司债券受托管理协议》（以下简 称"《受托管理协议》"）《金能科技股份有限公司公开发行 A 股可转换公司债券募 集说明书》（以下简称"《募集说明书》"）《金能科技股份有限公司 2024 年年度报 告》等相关公开信息披露文件、第三方中介机构出具的专业意见等，由本期债券受托管 理人中信证券股份有限公司（以下简称"中信证券"或"受托管理人"）编制。中信证 券对本报告中所包含的从上述文件中引述内容和信息未进行独立验证，也不就该等引述 内容和信息的真实性、准确性和完整性做出任何保证或承担任何责任。 本报告不构成对投资者进行或不进行某项行为的推荐意见，投资者应对相关事宜做 出独立判断，而不应将本报告中的任何内容据以作为中信证券所作的承诺或声明。在任 何情况下，投资者依据本报告 ...

| 证券代码：603113 | 证券简称：金能科技 | 公告编号：2025-060 | | --- | --- | --- | | 债券代码：113545 | 债券简称：金能转债 | | 金能科技股份有限公司 关于"金能转债"转股价格调整的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 证券停复牌情况：适用 因实施 2025 年第一季度权益分派,本公司的相关证券停复牌情况如下： | 证券代码 | 证券简称 | 停复牌类型 | 停牌起始日 | 停牌期间 | 停牌终止日 | 复牌日 | | --- | --- | --- | --- | --- | --- | --- | | 113545 | 金能转债 | 可转债转股复牌 | | | 2025/6/24 | 2025/6/25 | 1、调整前转股价格：9.87 元/股。 2、调整后转股价格：9.75 元/股。 3、转股价格调整生效日期：2025 年 6 月 25 日。 一、转股价格调整依据 经中国证券监督管理委员会《关于核准金能科技股份有限公司公开发行可转 ...

| | | 金能科技股份有限公司2025年第一季度权益分派实施公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 每股分配比例 A 股每股现金红利0.12元 相关日期 | 股份类别 | 股权登记日 | 最后交易日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | --- | --- | | Ａ股 | 2025/6/24 | － | 2025/6/25 | 2025/6/25 | 1. 发放年度：2025年第一季度 2. 分派对象： 四、 分配实施办法 1. 实施办法 差异化分红送转： 否 一、 通过分配方案的股东会届次和日期 本次利润分配方案经公司2025 年 5 月 13 日的2025年第二次临时股东大会审议通过。 二、 分配方案 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任公司上海分 公司（以下简称"中国结算上海分公司"）登记在册的本公司全体股东。 3. 分配方案： 本次利润分配以方案实施前的公司总股本847,952,378股为基数，每股派发现金红利0 ...

Core Viewpoint - The announcement details the adjustment of the conversion price for the company's convertible bonds, "Jineng Convertible Bonds," in response to profit distribution and other corporate actions. Group 1: Conversion Price Adjustment Basis - The company issued 15 million convertible bonds with a total value of 1.5 billion RMB on October 14, 2019, with a maturity of 6 years [1] - The conversion price is adjusted based on various corporate actions such as stock dividends, capital increases, and cash dividends, following specific formulas [1][2] Group 2: Historical Conversion Price Adjustments - In 2019, the conversion price was adjusted to 11.40 RMB/share after a cash dividend of 1.48 RMB per 10 shares [2] - In 2020, the conversion price was adjusted to 10.78 RMB/share following a non-public issuance of shares [3] - In 2021, the conversion price was adjusted to 10.43 RMB/share after a cash dividend of 3.48 RMB per 10 shares [4] - In 2022, the conversion price was adjusted to 9.96 RMB/share after a cash dividend of 1.20 RMB per 10 shares [5] - In 2023, the conversion price was adjusted to 9.87 RMB/share following a cash dividend of 0.94 RMB per 10 shares [6] Group 3: Upcoming Adjustments - For the first quarter of 2025, the company plans to distribute a cash dividend of 0.12 RMB per 10 shares, adjusting the conversion price to 9.75 RMB/share effective from June 25, 2025 [6]

Core Viewpoint - The company has announced a cash dividend distribution plan, with a total cash dividend of 101,754,285.36 yuan, amounting to 0.12 yuan per share before tax, approved at the second extraordinary general meeting of shareholders on May 13, 2025 [1]. Distribution Plan - The cash dividend distribution is based on a total share capital of 847,952,378 shares, with a cash dividend of 0.12 yuan per share, totaling 101,754,285.36 yuan [1]. - The record date for the dividend is June 24, 2025, with the last trading day on June 25, 2025, and the ex-dividend date also on June 25, 2025 [1]. Taxation Details - For individual shareholders holding unrestricted circulating shares, dividends are subject to different tax treatments based on the holding period, with a tax rate of 20% for holdings of one month or less, and 10% for holdings between one month and one year [3][4]. - For shareholders holding restricted shares, the tax is calculated based on the holding period post-lifting of restrictions, with a similar tax structure applied [4]. - Qualified Foreign Institutional Investors (QFII) will have a 10% withholding tax applied, resulting in a net cash dividend of 0.108 yuan per share [5]. Consultation Information - For inquiries regarding the dividend distribution, shareholders can contact the board office at 0534-2159288 [6].

| | | 金能科技股份有限公司 关于实施权益分派时"金能转债"停止转股暨转股价格 调整的提示性公告 3、本次权益分派方案实施后，将根据《金能科技股份有限公司公开发行 A 股 可转换公司债券募集说明书》的发行条款及相关规定，对"金能转债"转股价格 进行相应调整。 二、本次权益分派方案实施时停止转股的安排 1、公司将于 2025 年 6 月 18 日在上海证券交易所网站（www.sse.com.cn）及 指定媒体上发布权益分派实施公告和可转债转股价格调整公告。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 证券停复牌情况：适用 因实施2025年第一季度权益分派,本公司的相关证券停复牌情况如下：自2025 年第一季度权益分派实施公告前一交易日（2025 年 6 月 17 日）至权益分派股权登 记日期间，"金能转债"将停止转股。 | 证券代码 | 证券简称 | 停复牌类型 | 停牌起始日 | 停牌期间 | 停牌终止日 | 复牌日 | | --- | --- | --- | --- | --- | --- | --- ...

Group 1 - The company will stop the conversion of "Jinneng Convertible Bonds" during the rights distribution period, specifically from June 17, 2025, until the equity registration date [1][2] - The rights distribution plan involves a cash dividend of 1.20 yuan per 10 shares (including tax), with no increase in share capital or bonus shares [1][2] - Holders of "Jinneng Convertible Bonds" can convert their bonds until June 16, 2025, to enjoy the rights distribution [1][2] Group 2 - The company will announce the adjustment of the conversion price for "Jinneng Convertible Bonds" in accordance with the issuance terms and related regulations [2] - The resumption of bond conversion will occur on the first trading day after the equity registration date [2]

| | | 金能科技股份有限公司 关于实施权益分派时"金能转债"停止转股暨转股价格 调整的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 2、自权益分派公告前一交易日（2025 年 6 月 17 日）至权益分派股权登记日 期间，"金能转债"将停止转股，股权登记日后的第一个交易日起"金能转债"恢 复转股，欲享受权益分派的"金能转债"持有人可在 2025 年 6 月 16 日（含 2025 年 6 月 16 日）之前进行转股。 三、其他 联系部门：董事会办公室 证券停复牌情况：适用 因实施2025年第一季度权益分派,本公司的相关证券停复牌情况如下：自2025 年第一季度权益分派实施公告前一交易日（2025 年 6 月 17 日）至权益分派股权登 记日期间，"金能转债"将停止转股。 | 证券代码 | 证券简称 | 停复牌类型 | 停牌起始日 | 停牌期间 | 停牌终止日 | 复牌日 | | --- | --- | --- | --- | --- | --- | --- | | 113545 | 金能转债 ...

| 证券代码：603113 | 证券简称：金能科技 | 公告编号：2025-057 | | --- | --- | --- | | 债券代码：113545 | 债券简称：金能转债 | | 金能科技股份有限公司 关于为全资子公司提供担保的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 被担保人名称：金能科技股份有限公司（以下简称"公司"）之全资子公司 金能化学（青岛）有限公司（以下简称"金能化学青岛"）、金狮国际贸易（青 岛）有限公司（以下简称"金狮国贸青岛"）、金能化学（齐河）有限公司（以 下简称"金能化学齐河"）、金狮国际贸易（齐河）有限公司（以下简称"金狮 国贸齐河"）。 对外担保逾期的累计数量：无。 一、担保情况概述 （一）本次新增担保情况 1、中国民生银行股份有限公司青岛分行 为满足业务需求，保证生产顺利进行，金能化学青岛向中国民生银行股份有 限公司青岛分行（以下简称"民生银行"）申请开立人民币5,530.93万元信用证， 1 于2025年5月8日与民生银行签订编号为ZX25050001372 ...

Group 1 - Company Sun Energy plans to repurchase shares worth between 100 million to 200 million yuan for cancellation, with a maximum repurchase price of 6.69 yuan per share [1] - Company Runyang Technology intends to invest up to 300 million yuan in Shanghai Fourier Intelligent Technology Co., with a pre-investment valuation of 8 billion yuan [1] - Company Heng Rui Medicine's subsidiary has received approval for clinical trials of SHR-4712 injection for treating advanced solid tumors [2] Group 2 - Company Lianhuan Pharmaceutical plans to increase capital by 60 million yuan for its wholly-owned subsidiary [2] - Company Hongchang Electronics' subsidiary plans to increase capital by 10 million USD for its other subsidiary [2] - Company Sichuan Meifeng intends to repurchase shares worth between 50 million to 70 million yuan for cancellation, with a maximum repurchase price of 10.07 yuan per share [2] Group 3 - Company Lian Micro plans to liquidate and deregister Jiaxing Kangjing Semiconductor Industry Investment Partnership [4] - Company Jiutian Pharmaceutical has received approval for clinical trials of PDX-04 drug for treating acute gout attacks [5] - Company Pingzhi Information has signed a framework agreement with China Telecom for a GPU computing power project worth approximately 246 million yuan [7] Group 4 - Company Jiu Zhi Tang's subsidiary has initiated Phase II clinical trials for new drug YB211 aimed at treating acute bacterial skin infections [8] - Company Fosun Pharma's subsidiary has received orphan drug designation for HLX22 for gastric cancer treatment in the EU [9] - Company Jianyou Co. plans to repurchase shares worth between 20 million to 40 million yuan for employee stock ownership plans [11] Group 5 - Company Zhi Zheng Co. announced the resignation of its vice president due to personal reasons [13] - Company He Mai Co. signed a cooperation agreement for household photovoltaic systems worth 1 billion yuan [14] - Company Jinan Intelligent's subsidiary won a project bid for electric vehicle charging stations, expected to positively impact performance [16] Group 6 - Company Gaotie Electric plans to distribute a cash dividend of 0.012 yuan per share [18] - Company Guyue Longshan plans to distribute a cash dividend of 0.08 yuan per share [18] - Company Yongmaotai's shareholders plan to reduce their holdings by up to 2.66% of the company's shares [19] Group 7 - Company Tian Cheng Technology's subsidiary received a land idle fee notice for 2.1658 million yuan due to project delays [20] - Company Guangri Co. appointed a new vice president and board secretary to enhance governance [21] - Company Design General Institute won multiple major projects totaling approximately 390 million yuan [22] Group 8 - Company Fuxie Environmental signed a significant contract worth 244 million yuan for a sewage treatment project [23] - Company Lujiazui announced the resignation of its vice chairman due to job transfer [24] - Company Three Squirrels' H-share issuance application has been accepted by the CSRC [24] Group 9 - Company Kanghong Pharmaceutical's subsidiary received approval for clinical trials of KH617 for glioblastoma treatment [25] - Company Xin Zhu Co. announced a suspension of trading to plan an asset acquisition from its controlling shareholder [26] - Company Jianxin Co. announced plans for share reductions by several directors and senior management [28]